04:55 PM EDT, 07/02/2025 (MT Newswires) -- Cellectar Biosciences ( CLRB ) said late Wednesday it closed a public offering of units for gross proceeds of about $6.9 million.

The offering included over 1 million class A units priced at $5 each, comprising one common share and one warrant to purchase a common share. That total includes 180,000 class A units issued following the full exercise of the underwriters' overallotment option.

Cellectar also sold 335,000 class B units at $4.99999 each, with each unit consisting of a pre-funded warrant to buy one common share and one common warrant.

The company said it plans to use the net proceeds for general corporate purposes.